Innate and adaptive immunity in inflammatory bowel disease
- PMID: 21912465
- PMCID: PMC3158392
- DOI: 10.3748/wjg.v17.i27.3178
Innate and adaptive immunity in inflammatory bowel disease
Abstract
Inflammatory bowel diseases are the consequence of a dysregulated mucosal immune system. The mucosal immune system consists of two arms, innate and adaptive immunity, that have been studied separately for a long time. Functional studies from in vivo models of intestinal inflammation as well as results from genome-wide association studies strongly suggest a cross-regulation of both arms. The present review will illustrate this interaction by selecting examples from innate immunity and adaptive immunity, and their direct impact on each other. Broadening our view by focusing on the cross-regulated areas of the mucosal immune system will not only facilitate our understanding of disease, but furthermore will allow identification of future therapeutic targets.
Keywords: Immune system; Inflammatory bowel diseases.
Figures
References
-
- Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427–434. - PubMed
-
- Huang JS, Noack D, Rae J, Ellis BA, Newbury R, Pong AL, Lavine JE, Curnutte JT, Bastian J. Chronic granulomatous disease caused by a deficiency in p47(phox) mimicking Crohn‘s disease. Clin Gastroenterol Hepatol. 2004;2:690–695. - PubMed
-
- Schinella RA, Greco MA, Cobert BL, Denmark LW, Cox RP. Hermansky-Pudlak syndrome with granulomatous colitis. Ann Intern Med. 1980;92:20–23. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
